SecBot SecBot
SECBOTREPLAY Home › Report › ICCC

ICCC · Q3 rev +46%, net income $953K

ImmuCell Corporation · PRESS-RELEASE filed Nov 12, 2026 at 16:05 ET

At the news

BULLISHIMPACT 5/10

PRESS-RELEASE filed Nov 12, 2026 at 16:05 ET

ImmuCell reported Q3 2026 net income of $953,000 ($0.10/diluted share) versus a net loss of $140,000 in Q3 2025, with product sales up 46% to $8.0 million. The company also terminated its At-The-Market offering and is negotiating a new $3 million line of credit.

  • Q3 2026 product sales $8.0M, up 46% from $5.5M in Q3 2025
  • Net income $953,000 ($0.10/diluted) vs net loss $140,000 in Q3 2025
  • Gross margin improved to 44.2% from 42.9%
  • Adjusted EBITDA $1.9M vs $0.8M in Q3 2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access